Incidental Mutation 'R9280:Ilf2'
ID 703546
Institutional Source Beutler Lab
Gene Symbol Ilf2
Ensembl Gene ENSMUSG00000001016
Gene Name interleukin enhancer binding factor 2
Synonyms Tex261, 6230405A16Rik, TEG-267, Tex267
MMRRC Submission
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R9280 (G1)
Quality Score 225.009
Status Validated
Chromosome 3
Chromosomal Location 90383433-90395686 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 90394922 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Glutamic Acid to Glycine at position 390 (E390G)
Ref Sequence ENSEMBL: ENSMUSP00000001042 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000001042] [ENSMUST00000149884] [ENSMUST00000184877] [ENSMUST00000185005]
AlphaFold Q9CXY6
PDB Structure Crystal structure of the NF90-NF45 dimerisation domain complex [X-RAY DIFFRACTION]
Crystal structure of the NF90-NF45 dimerisation domain complex with ATP [X-RAY DIFFRACTION]
Crystal structure of the NF90-NF45 dimerisation domain complex with UTP [X-RAY DIFFRACTION]
Crystal structure of the NF90-NF45 dimerisation domain complex with CTP [X-RAY DIFFRACTION]
Predicted Effect unknown
Transcript: ENSMUST00000001042
AA Change: E390G
SMART Domains Protein: ENSMUSP00000001042
Gene: ENSMUSG00000001016
AA Change: E390G

DomainStartEndE-ValueType
low complexity region 2 26 N/A INTRINSIC
DZF 98 338 5.01e-142 SMART
low complexity region 353 390 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000149884
SMART Domains Protein: ENSMUSP00000122090
Gene: ENSMUSG00000001018

DomainStartEndE-ValueType
low complexity region 2 19 N/A INTRINSIC
Pfam:Snapin_Pallidin 23 110 5.8e-31 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000184877
SMART Domains Protein: ENSMUSP00000139315
Gene: ENSMUSG00000001018

DomainStartEndE-ValueType
low complexity region 2 19 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000185005
SMART Domains Protein: ENSMUSP00000139160
Gene: ENSMUSG00000001018

DomainStartEndE-ValueType
low complexity region 2 19 N/A INTRINSIC
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 100.0%
  • 10x: 99.7%
  • 20x: 99.1%
Validation Efficiency 100% (63/63)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is a transcription factor required for T-cell expression of the interleukin 2 gene. It also binds RNA and is an essential component for encapsidation and protein priming of hepatitis B viral polymerase. The encoded 45 kDa protein (NF45, ILF2) forms a complex with the 90 kDa interleukin enhancer-binding factor 3 (NF90, ILF3), and this complex has been shown to affect the redistribution of nuclear mRNA to the cytoplasm, to repair DNA breaks by nonhomologous end joining, and to negatively regulate the microRNA processing pathway. Knockdown of NF45 or NF90 protein retards cell growth, possibly by inhibition of mRNA stabilization. Alternative splicing results in multiple transcript variants. Related pseudogenes have been found on chromosomes 3 and 14. [provided by RefSeq, Dec 2014]
PHENOTYPE: Mice homozygous for a knock-out allele exhibit embryonic lethality. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 65 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Acrbp G T 6: 125,039,938 (GRCm39) V514L probably damaging Het
Actl11 A G 9: 107,808,573 (GRCm39) I965M probably damaging Het
Ank3 A T 10: 69,818,021 (GRCm39) S1468C possibly damaging Het
Aoc1l1 A G 6: 48,955,116 (GRCm39) D652G possibly damaging Het
Apobec3 A C 15: 79,791,082 (GRCm39) N392T Het
Ccdc33 A T 9: 57,965,549 (GRCm39) M591K probably benign Het
Ccdc39 T C 3: 33,870,153 (GRCm39) E689G probably damaging Het
Cnot1 A T 8: 96,497,227 (GRCm39) M250K probably benign Het
Crppa T A 12: 36,571,975 (GRCm39) S344R probably benign Het
Ctbs A T 3: 146,160,142 (GRCm39) Y57F probably damaging Het
Dchs2 A G 3: 83,189,255 (GRCm39) I1540V possibly damaging Het
Dnah8 A T 17: 31,004,071 (GRCm39) Q3651H possibly damaging Het
Eif2a A G 3: 58,447,009 (GRCm39) probably benign Het
Entpd2 A G 2: 25,289,511 (GRCm39) N331S possibly damaging Het
F830045P16Rik G A 2: 129,314,774 (GRCm39) P168S probably damaging Het
Fam76b A T 9: 13,751,012 (GRCm39) H302L possibly damaging Het
Fancm A G 12: 65,153,612 (GRCm39) E1356G probably benign Het
Fat2 G A 11: 55,201,523 (GRCm39) T517I probably benign Het
Glul T C 1: 153,783,611 (GRCm39) C269R probably benign Het
Gm3404 C T 5: 146,462,756 (GRCm39) H40Y possibly damaging Het
Grb7 T C 11: 98,345,248 (GRCm39) F435S probably damaging Het
Ide A T 19: 37,295,490 (GRCm39) Y191N Het
Ide T C 19: 37,307,801 (GRCm39) probably benign Het
Ighv6-3 T A 12: 114,355,420 (GRCm39) T90S probably damaging Het
Il23r A G 6: 67,429,410 (GRCm39) C311R probably damaging Het
Ints1 C T 5: 139,750,469 (GRCm39) C896Y probably damaging Het
Ipcef1 T C 10: 6,850,736 (GRCm39) E289G probably benign Het
Kbtbd2 G A 6: 56,755,997 (GRCm39) R580W probably damaging Het
Kif21b T C 1: 136,099,445 (GRCm39) probably null Het
Ltbp2 G A 12: 84,837,864 (GRCm39) P1192L probably benign Het
Mmp27 A T 9: 7,579,812 (GRCm39) I429L probably benign Het
Mmp8 A G 9: 7,567,292 (GRCm39) D431G possibly damaging Het
Mpeg1 A G 19: 12,439,828 (GRCm39) T429A probably benign Het
Mterf1a A T 5: 3,941,539 (GRCm39) Y110N probably damaging Het
Myh4 G A 11: 67,146,135 (GRCm39) A1398T probably damaging Het
Nr3c2 T A 8: 77,635,973 (GRCm39) M358K probably benign Het
Nup50l A C 6: 96,141,982 (GRCm39) L354R probably damaging Het
Or5d14 A T 2: 87,880,458 (GRCm39) F170Y probably damaging Het
Or5g25 G A 2: 85,478,504 (GRCm39) R54* probably null Het
Or7e173 A C 9: 19,938,639 (GRCm39) S198R probably benign Het
Otof A G 5: 30,528,894 (GRCm39) F1838S probably damaging Het
Pappa2 G A 1: 158,675,533 (GRCm39) T1071I possibly damaging Het
Pcdhb15 A G 18: 37,607,794 (GRCm39) D342G probably damaging Het
Pcdhgb7 T C 18: 37,886,585 (GRCm39) L585P probably damaging Het
Pde1c A T 6: 56,114,505 (GRCm39) S469R probably benign Het
Pla2g6 A G 15: 79,197,314 (GRCm39) F87L probably benign Het
Rag2 A T 2: 101,460,145 (GRCm39) M152L probably benign Het
Rasa1 C T 13: 85,436,732 (GRCm39) A99T unknown Het
Rasgrp1 T C 2: 117,113,132 (GRCm39) N760S probably benign Het
Rgsl1 A T 1: 153,669,898 (GRCm39) M232K probably benign Het
Ryr1 G A 7: 28,802,389 (GRCm39) H744Y probably damaging Het
Slc1a4 A G 11: 20,282,325 (GRCm39) S50P probably damaging Het
Slc25a36 A C 9: 96,982,233 (GRCm39) L34R probably damaging Het
Slc39a12 A T 2: 14,401,003 (GRCm39) I127F probably benign Het
Slco1a8 A G 6: 141,939,978 (GRCm39) L175P possibly damaging Het
Sntb1 T C 15: 55,769,771 (GRCm39) T73A probably benign Het
Tbc1d14 T C 5: 36,680,268 (GRCm39) probably benign Het
Tll2 T A 19: 41,077,309 (GRCm39) E819V possibly damaging Het
Trappc13 C T 13: 104,290,809 (GRCm39) A181T probably benign Het
Trbj1-1 A G 6: 41,510,830 (GRCm39) R11G Het
Ubash3b A C 9: 41,072,877 (GRCm39) I12S unknown Het
Usp37 T C 1: 74,489,699 (GRCm39) K828E probably damaging Het
Usp8 G C 2: 126,561,944 (GRCm39) S46T unknown Het
Zfp418 A G 7: 7,184,408 (GRCm39) T124A possibly damaging Het
Zfp87 T C 13: 74,520,803 (GRCm39) T92A probably benign Het
Other mutations in Ilf2
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01585:Ilf2 APN 3 90,391,849 (GRCm39) missense probably damaging 1.00
R0193:Ilf2 UTSW 3 90,388,646 (GRCm39) splice site probably null
R0746:Ilf2 UTSW 3 90,390,114 (GRCm39) missense probably damaging 1.00
R1888:Ilf2 UTSW 3 90,394,767 (GRCm39) unclassified probably benign
R3912:Ilf2 UTSW 3 90,394,367 (GRCm39) missense probably benign 0.07
R4441:Ilf2 UTSW 3 90,394,769 (GRCm39) missense probably benign 0.18
R7957:Ilf2 UTSW 3 90,394,777 (GRCm39) nonsense probably null
R9001:Ilf2 UTSW 3 90,390,108 (GRCm39) missense probably benign 0.07
R9492:Ilf2 UTSW 3 90,394,570 (GRCm39) missense probably benign 0.00
X0011:Ilf2 UTSW 3 90,394,782 (GRCm39) missense probably benign 0.01
Predicted Primers PCR Primer
(F):5'- AGAGAAGCCGTATCTAAAGGTGGTC -3'
(R):5'- AGACTTCTAGCTGCTTGGCC -3'

Sequencing Primer
(F):5'- ACTGGGATATTTGTATGAAGTGGG -3'
(R):5'- GCTTGGCCACTATCGAAACAGTAG -3'
Posted On 2022-03-25